The underlying hypothesis is that disrupting the enzymatic activity of HSP90 would reverberate on the chaperone protein folding machinery, simultaneously affecting multiple oncoproteins that are essential to the proliferation and maintenance of cancer cells. Here, HSP90AB1 is linked to cancer.